Medvacon Contributes to The COVID Vaccine

November 20, 2020 (NJ) Medvacon Life Sciences a Quality, Compliance and
Validation consulting company is contributing to the mRNA production of vaccines to prevent
the COVID 19 virus by ensuring that the cutting edge technology meet s the stringent
expectations of the FDA. Medvacon is supporting companies in the areas of process validation,
verification, cleaning validation, facility and utility qualification as well as process development.

“We are proud to be supporting companies developing mRNA based products in support of the
ongoing efforts to develop a COVID 19 vaccine said Joe Toscano, one of the founding
members of the life sciences company. We have a depth of industry experience and expertise to
support these companies in rapidly developing markets and launching their new products to
meet the urgent demands of COVID 19 vaccine development,” he continued.

As current demand for commercial scale GMP (Good Manufa cturing Practice s RNA and
plasmid products ha ve seen rapid growth recently, and pharmaceutical, vaccine, and biotech
companies are rapidly expanding their current manufacturing capacity to meet demand. RNA
stands for ribonucleic acid, a nucleic acid pres ent in all living cells. Its principal role is to act as a
messenger carrying instructions from DNA for controlling the synthesis of proteins, although in
some viruses RNA rather than DNA carries the genetic information. DNA is a self replicating
materia l that is present in nearly all living organisms as the main constituent of chromosomes. It
is the carrier of genetic information.

Medvacon is helping to expand current manufacturing capacity to best in class GMP capping
reagents with GMP filling capabili ties at full commercial scale, including the design and building
of state of the art facilities for mRNA and DNA based components in support of commercial
scale GMP production. Medvacon is supporting clients in the areas of validation s upport
activities, including: equipment qualification, facility and utility qualification, cleaning
validation, validation planning supporting quality documentation, as well as conducting process
verification validation The FDA defines p rocess validation as establishing by objective
evidence that a process consistently produces a result or product meeting its predetermined
specifications.

Medvacon is a full service Quality and Compliance consulting firm offering a suite of quality
servic es such as: Quality Systems Implementation and Remediation; Computer System
Validation; Process and Cleaning Validation; Equipment, Facility and Utility Qualification;
Mock FDA Inspections and Audits; Project Management and cGMP Training. These services
help clients to ensure FDA Compliance and reduce compliance cost in the Life Sciences’
industry. The company provides experienced project administration, trouble shooting, and/or
training services, on site, with local resources and senior management invo lvement to optimize
flow and collaboration. Headquartered in Sparta, NJ, Medvacon Life Sciences also has offices in
San Diego California. More information can be found at http://www.Medvacon.com